References
- Wanless IR. (1990). Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787–97.
- Schnelldorfer T, Ware AL, Smoot R, et al. (2010). Management of giant hemangioma of the liver: resection versus observation. J Am Coll Surg 211:724–30.
- Corigliano N, Mercantini P, Amodio PM, et al. (2003). Hemoperitoneum from a spontaneous rupture of a giant hemangioma of the liver: report of a case. Surg Today 33:459–63.
- Watzke HH, Linkesch W, Hay U. (1989). Giant hemangioma of the liver (Kasabach-Merritt syndrome): successful suppression of intravascular coagulation permitting surgical removal. J Clin Gastroenterol 11:347–50.
- Singh RK, Kapoor S, Sahni P, Chattopadhyay TK. (2007). Giant haemangioma of the liver: is enucleation better than resection?. Ann R Coll Surg Engl 89:490–3.
- Giavroglou C, Economou H, Ioannidis I. (2003). Arterial embolization of giant hepatic hemangiomas. Cardiovasc Intervent Radiol 26:92–6.
- Gaspar L, Mascarenhas F, da Costa MS, et al. (1993). Radiation therapy in the unresectable cavernous hemangioma of the liver. Radiother Oncol 29:45–50.
- Mahajan D, Miller C, Hirose K, et al. (2008). Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol 49:867–80.
- Clarke D, Currie E, Madhavan K, et al. (2004). Hepatic resection for benign noncystic liver lesions. HPB (Oxford) 6:115–19.
- Huang ZQ, Xu LN, Yang T, et al. (2009). Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases. Chin Med J (Engl) 122:2268–77.
- Shrivastava DN, Gandhi D, Seith A, et al. (2001). Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdom Imaging 26:510–14.
- Huang XQ, Huang ZQ, Duan WD, et al. (2002). Severe biliary complications after hepatic artery embolization. World J Gastroenterol 8:119–23.
- Hinshaw JL, Laeseke PJ, Weber SM, Lee FT Jr. (2007). Multiple-electrode radiofrequency ablation of symptomatic hepatic cavernous hemangioma. AJR Am J Roentgenol 189:W146–9.
- Park SY, Tak WY, Jung MK, et al. (2011). Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonography-guided radiofrequency ablation. J Hepatol 54:559–65.
- Gao J, Ke S, Ding XM, et al. (2013). Radiofrequency ablation for large hepatic hemangiomas: Initial experience and lessons. Surgery 153:78–85.
- Sharpe EE III, Dodd GD III. (2012). Percutaneous radiofrequency ablation of symptomatic giant hepatic cavernous hemangiomas: report of two cases and review of literature. J Vasc Interv Radiol 23:971–5.
- Wright AS, Sampson LA, Warner TF, et al. (2005). Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236:132–9.
- Ziemlewicz TJ, Wells SA, Lubner MA, et al. (2014). Microwave ablation of giant hepatic cavernous hemangiomas. Cardiovasc Intervent Radiol 37:1299–305.
- van Tilborg AA, Dresselaars HF, Scheffer HJ, et al. (2016). RF ablation of giant hemangiomas inducing acute renal failure: a report of two cases. Cardiovasc Intervent Radiol 39:1644–8.
- Li GW, Chen QL, Jiang JT, Zhao ZR. (2003). The origin of blood supply for cavernous hemangioma of the liver. Hepatobiliary Pancreat Dis Int 2:367–70.
- Sacks D, McClenny TE, Cardella JF, Lewis CA. (2003). Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202.
- Miura JT, Amini A, Schmocker R, et al. (2014). Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford) 16:924–8.
- Ji J, Gao J, Zhao L, et al. (2016 Apr). Computed tomography-guided radiofrequency ablation following transcatheter arterial embolization in treatment of large hepatic hemangiomas. Medicine (Baltimore) 95:e3402.
- Liang P, Wang Y, Yu X, Dong B. (2009). Malignant liver tumors: treatment with percutaneous microwave ablation–complications among cohort of 1136 patients. Radiology 251:933–40.
- Yu J, Liang P, Yu XL, et al. (2012). US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology 263:900–8.
- Vogl TJ, Naguib NN, Gruber-Rouh T, et al. (2011). Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology 261:643–51.
- Brace CL, Diaz TA, Hinshaw JL, Lee FT Jr. (2010). Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol 21:1280–6.
- Cui Y, Zhou LY, Dong MK, et al. (2003). Ultrasonography guided percutaneous radiofrequency ablation for hepatic cavernous hemangioma. World J Gastroenterol 9:2132–4.